Cellular distribution and contribution of cyclooxygenase (COX)-2 to diabetogenesis in NOD mouse
✍ Scribed by Cheng Luo; Markku Kallajoki; Rene Gross; Mika Mulari; Tamara Teros; Laura Ylinen; Marjaana Mäkinen; Jukka Laine; Olli Simell
- Book ID
- 106138518
- Publisher
- Springer-Verlag
- Year
- 2002
- Tongue
- English
- Weight
- 361 KB
- Volume
- 310
- Category
- Article
- ISSN
- 0302-766X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
To study the possible role of the isoenzymes of cyclooxygenase COX-1 and COX-2 in the MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) mouse model of Parkinson's disease we used acetylsalicylic acid, a COX-1/COX-2 inhibitor, in comparison with meloxicam, a preferential COX-2 inhibitor. As markers
The nonobese diabetic (NOD) mouse spontaneously develops an autoimmune diabetes that shares many immunogenetic features with human insulin-dependent diabetes mellitus (IDDM), type 1 diabetes. The mononuclear cell infiltrates in the islet, which results in the development of insulitis (a prerequisite
## Abstract Apigenin is a bioflavonoid with chemopreventive activity against UV‐ or chemically‐induced mouse skin tumors. To further explore the mechanism of apigenin's chemopreventive activity, we determined whether apigenin inhibited UVB‐mediated induction of cyclooxygenase‐2 (COX‐2) expression i
## Abstract The mechanisms whereby cyclooxygenase‐2 (COX‐2) overexpression may contribute to bladder carcinogenesis remain unknown. We recently developed a transgenic mouse model overexpressing COX‐2 under the control of a bovine keratin 5 (BK5) promoter causing a high incidence of transitional cel
## Abstract Previous studies from our laboratory and others have suggested that increased expression of __cox‐2__ is important in the genesis of esophageal adenocarcinoma. __In vitro__ studies suggest that __cox‐2__ regulates expression of the anti‐apoptotic protein bcl‐2, thus possibly accounting